University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

HDFCCC Hematopoietic Malignancies Program & UCSF Molecular Medicine Joint Seminar

October 24, 2017, 4:00 pm – 5:00 pm

San Francisco, 94143

“Imatinib as a Paradigm of Targeted Cancer Therapies”

Brian Druker, MD
Director, Knight Cancer Institute at Oregon Health & Science University
JELD-WEN Chair of Leukemia Research
Investigator, Howard Hughes Medical Institute

Dr. Druker has received the Lasker-DeBakey Award for Clinical Medical Research. He is a member of the National Academy of Sciences and the American Academy of Arts and Sciences.

Contact Information


See more events